RELIEF THERAPEUTICS HOLDING/ CH1251125998 /
| 15/11/2024 16:42:32 | Chg. -1.42 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 6.02CHF | -19.09% | 491 Turnover: 2,955.82 |
-Bid Size: - | -Ask Size: - | 85.65 mill.CHF | - | - |
Assets
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .5000 | .7000 | 2.4000 | 0.0000 | 0.0000 | ||||||
| Intangible Assets | 0.0000 | 27.4000 | 23.4000 | 20.8000 | 30.8000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | .5000 | 28.2000 | 25.9000 | 20.8000 | 30.8000 | ||||||
| Inventories | 0.0000 | 2.2000 | .5000 | 0.0000 | 0.0000 | ||||||
| Accounts Receivable | .3000 | 3.5000 | 3.1000 | 0.0000 | 0.0000 | ||||||
| Cash and Cash Equivalents | .3000 | .8000 | 4.2000 | .3000 | .4000 | ||||||
| Current Assets | .6000 | 10 | 8.7000 | 7.1000 | .6000 | ||||||
| Total Assets | 1.1000 | 38.2000 | 34.6000 | 27.9000 | 31.4000 | ||||||
Liabilities
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | .7000 | 6.2000 | 3.9000 | .4000 | .4000 | ||||||
| Long-term debt | .1000 | 3.7000 | 1.4000 | 1.9000 | - | ||||||
| Liabilities to Banks | 2.3000 | 8 | 4.5000 | 4.2000 | 0.0000 | ||||||
| Provisions | .2000 | 1.4000 | 1.2000 | .7000 | 6.5000 | ||||||
| Liabilities | 3.3000 | 21.4000 | 12.7000 | 11.5000 | 9.2000 | ||||||
| Share Capital | .6000 | 3.2000 | 5.4000 | 5.4000 | 19.5000 | ||||||
| Total Equity | -2.2000 | 16.4000 | 21.9000 | 16.3000 | 22.2000 | ||||||
| Minority Interests | 0.0000 | .4000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 1.1000 | 38.2000 | 34.6000 | 27.9000 | 31.4000 | ||||||
Income Statement
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 0.0000 | 16.9000 | 16.2000 | .2000 | 0.0000 | ||||||
| Depreciation (total) | .3000 | 1.7000 | 5.2000 | .3000 | 14.5000 | ||||||
| Operating Result | -5.2000 | -9.4000 | -10.1000 | -3.5000 | -16.5000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -5.4000 | -10.2000 | -10.4000 | -4 | -16.8000 | ||||||
| Income Taxes | 0.0000 | .2000 | .2000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -5.4000 | -10 | -10.2000 | -8.5000 | -16.8000 | ||||||
Per Share
Cash Flow
| 2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -3.8000 | -7.2000 | -7.3000 | -6.2000 | -2.9000 | ||||||
| Cash Flow from Investing Activities | 0.0000 | -.8000 | -.5000 | 1 | .1000 | ||||||
| Cash Flow from Financing | 2.7000 | 7.8000 | 11.2000 | 2.1000 | 3.1000 | ||||||
| Decrease / Increase in Cash | -1.2000 | 0.0000 | 3.4000 | -3 | .4000 | ||||||
| Employees | - | - | - | - | - | ||||||
